Skip to main content
Earnings Labs
Beam Therapeutics Inc. logo

Beam Therapeutics Inc. (BEAM)

NASDAQ·Healthcare·Biotechnology

$33.53

+8.20%

Mkt Cap $3.03B

Analyst Ratings

Buy

4

Hold

0

Sell

0

Price Target (17 analysts)

$40.83

Range $26.00$74.00

Implied Upside

+21.8%

Consensus $40.83 vs current $33.53